Our gentleMACS Technology allows tumor dissociation while preserving cell surface epitopes. Thus, tumor-infiltrating B cells (TIBs) can be isolated fast and easy with MACS® Technology. Optimized flow cytometry reagents then enable you to analyze the TIBs. Discover this complete workflow for TIB research.
Tune into our webinar to learn about the role of B cell immunotherapies, and therapeutic antibodies in immuno-oncology research.
Anne Richter, Ramona Siemer, Elvira Criado-Moronati, Anna Baranska, Philipp Gert, David Agorku, Olaf Hardt, Daniela Vorholt, Aparajita Singh, Ruth Kläver, Christian Dose, Bianca Heemskerk, and César Evaristo
In order to study tumor infiltrating B cells (TIBs), the tumor first has to be dissociated into a single cell suspension. For this, the gentleMACS™ Dissociator in combination with the Tumor Dissociation Kit, human ensures rapid and standardized dissociation of tissue samples into single-cell suspensions. Whatever the tumor entity, gentleMACS Technology provides excellent cell viability and functionality for further downstream cell separation, analysis, and culture.
Get more information on our solutions for analysis of tumor composition and microenvironment here.
Watch how the gentleMACS Dissociator can help speed up your workflow of dissociating tumor tissue.
To isolate tumor infiltration B cells (TIBs) positive selection positive selection is recommended, due to the highly diverse sample composition, tumor type, and origin, as well as patient differences. Whether you require for your experiments, label free B cell or classical B cell isolation using CD19 MicroBeads or cells isolated using a flow cytometer, we have a solution for you.
The amount and composition of tumor-infiltrating leukocytes (TILs) is highly variable, complicating the analysis of B cell populations. However, TIB numbers are often very low and may escape analysis when they are lost in background noise. This can be especially challenging when performing single-cell analysis. Moreover, a prerequisite for single-cell analysis is a debris-free single-cell suspensions with a viability above 80%. When working with large cohort sizes, immunophenotyping of TIBs by flow cytometry is time consuming and the data processing can be intense. Therefore, pre-enrichment is highly desirable to increase the sensitivity of analysis, saving time and effort during flow cytometry.
REAlease® Technology allows for magnetic cell isolation with subsequent removal of any beads and labels from your cells of interest. Clever utilization of recombinant antibody fragments ensures cell surface labeling in just a few steps.
The technology relies on recombinantly engineered antibody fragments for cell surface labeling for highly reproducible results. The REAlease Biotin Complex binds to the target cells. Labeling of the REAlease Biotin Complex with Anti-Biotin MicroBeads allows for magnetic isolation of these cells. Following cell separation, both MicroBeads and REAlease Biotin Complex are gently removed, leaving the cells bead- and label-free. Enriched cells are then suitable for magnetic re-labeling and any application where label-free cells are essential.
The MACSQuant® Tyto® Cell Sorter is revolutionizing cell sorting. Our patented microchip-based technology opens up new possibilities with high-speed multiparameter cell sorting in the safety of a fully enclosed and sterile cartridge system, the MACSQuant Tyto Cartridge. This enables gentle sorting of TIBs, leading to high target cell purity and viability of theses rare cells.
Curious how cell sorting within the MACSQuant Tyto Cartridge works?
Learn in detail how the unique microchip-based technology enables high-speed, fluorescence-based cell sorting with the world’s fastest mechanical sort valve. Sorting your cells has never been gentler and more reliable!
When working with rare cell populations such as TIBs ex vivo cultivation is often used to increase B cells in numbers; either to study their biology, or transform them and analyze their antibody production as well as specificity. This can often be difficult, however using the B Cell Expansion Kit, human, streamlines and simplifies the process. The formulation offers the perfect solution to expand and activate human B cells from various sources which are fully functional and ready for any downstream application.
Reliable activation and expansion of B cells is a clear requirement for effective downstream experiments. The B Cell Expansion Kit consist of a recombinant CD40L multimer, a cross-linking antibody, and IL-4. Cross-linking of CD40 expressed on B cells leads to cell activation and proliferation. Combining CD40L together with IL-4, which is a known growth factor for activated B cells, has been shown to be crucial for effective activation and proliferation of B cells.
Expanded B cells display an activated phenotype with a distribution of memory and plasma cells similar to the original fraction. The amounts of naive B cells decreased under all culture conditions on day 14. Likewise, reports describe that naive B cells have a shorter survival rate.
Aparajita Singh, Susanne Bethke, Daniela Vorholt, and Andrzej Dzionek
As the final step in many workflows, flow analysis plays an important part in the analysis of TIBs. Definition and distribution of subsets, differentiation and activation status of the cell in the tumor are of special interest. Our flow reagents ensure that the data you generate on your flow cytometer is reliable and consistent:
Christiane Siewert, Karin Hartmann, and Thomas Nebe
Seems like you are coming from USA!
Do you want to visit our website in your country?